Fundz Deep Dive
Everything you need to win Aspira Women’s Health — in one platform.
Who to reach, what to say, and why now on Aspira Women’s Health — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Aspira Women’s Health — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Aspira Women's Health Secures $10M Federal Contract for ENDOinform Development
Nov 14, 2024•over 1 year ago
Contract Type
contract
Description
Aspira Women’s Health Inc. reported selected financial results for the third quarter ended September 30, 2024, highlighting the 27% growth of OvaWatch® product volume. The company also announced the award of a $10 million ARPA-H contract to fund the development and commercial launch of ENDOinformSM within the next 24 months.
Related People
Suggested for you
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months